Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,246 | 37,909 | 35,964 | 33,718 | 33,776 |
| Receivables | 18,737 | 17,613 | 13,184 | 14,859 | 12,043 |
| TOTAL | $58,910 | $56,699 | $49,953 | $49,450 | $46,979 |
| Non-Current Assets | |||||
| PPE Net | 1,108 | 2,160 | 3,056 | 4,157 | 5,327 |
| Other Non-Current Assets | 2,131 | 1,694 | 1,199 | 1,208 | 0 |
| TOTAL | $3,240 | $3,853 | $4,255 | $5,365 | $5,327 |
| Total Assets | $62,149 | $60,553 | $54,208 | $54,815 | $52,306 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,148 | 5,739 | 4,293 | 5,389 | 5,431 |
| TOTAL | $18,997 | $17,807 | $13,324 | $13,787 | $6,023 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 502 | 4,996 |
| TOTAL | $0 | $0 | $0 | $502 | $5,000 |
| Total Liabilities | $18,997 | $17,807 | $13,324 | $14,289 | $11,023 |
| Shareholders' Equity | |||||
| Common Shares | 20,578 | 21,529 | 38,311 | 39,772 | 41,449 |
| Retained earnings | 4,558 | 2,366 | 1,935 | 112 | -829 |
| Other shareholders' equity | 22 | 26 | 0 | -20 | -20 |
| TOTAL | $43,153 | $42,746 | $40,884 | $40,526 | $41,283 |
| Total Liabilities And Equity | $62,149 | $60,553 | $54,208 | $54,815 | $52,306 |